Chugai Pharmaceutical Co., Ltd. (CHGCF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
As of 03:40PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 54.76B |
| Enterprise Value | 49.76B |
| Trailing P/E | 25.47 |
| Forward P/E | 23.70 |
| PEG Ratio (5 yr expected) | 7.18 |
| Price/Sales (ttm) | 8.02 |
| Price/Book (mrq) | 5.06 |
| Enterprise Value/Revenue | 0.05 |
| Enterprise Value/EBITDA | 0.11 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.48 |
| 52-Week Change 3 | 24.73% |
| S&P500 52-Week Change 3 | 22.38% |
| 52 Week High 3 | 43.72 |
| 52 Week Low 3 | 26.00 |
| 50-Day Moving Average 3 | 37.71 |
| 200-Day Moving Average 3 | 33.67 |
Share Statistics
| Avg Vol (3 month) 3 | 506 |
| Avg Vol (10 day) 3 | 120 |
| Shares Outstanding 5 | 1.65B |
| Implied Shares Outstanding 6 | 1.69B |
| Float 8 | 639.35M |
| % Held by Insiders 1 | 59.91% |
| % Held by Institutions 1 | 18.63% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 0.56 |
| Forward Annual Dividend Yield 4 | 1.72% |
| Trailing Annual Dividend Rate 3 | 80.00 |
| Trailing Annual Dividend Yield 3 | 246.69% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 40.33% |
| Dividend Date 3 | Sept 01, 2017 |
| Ex-Dividend Date 4 | Jun 27, 2024 |
| Last Split Factor 2 | 3:1 |
| Last Split Date 3 | Jun 29, 2020 |
Financial Highlights
Currency in JPY.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 31.50% |
| Operating Margin (ttm) | 42.15% |
Management Effectiveness
| Return on Assets (ttm) | 15.01% |
| Return on Equity (ttm) | 21.20% |
Income Statement
| Revenue (ttm) | 1.04T |
| Revenue Per Share (ttm) | 629.73 |
| Quarterly Revenue Growth (yoy) | -24.10% |
| Gross Profit (ttm) | N/A |
| EBITDA | 467.56B |
| Net Income Avi to Common (ttm) | 326.37B |
| Diluted EPS (ttm) | 1.27 |
| Quarterly Earnings Growth (yoy) | 1.20% |
Balance Sheet
| Total Cash (mrq) | 764.57B |
| Total Cash Per Share (mrq) | 464.67 |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.53 |
| Book Value Per Share (mrq) | 997.97 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 383.09B |
| Levered Free Cash Flow (ttm) | 287.75B |
© 2024 Yahoo. All rights reserved.